7/19/20187/19/2018
Nobia has on July 13, 2018 entered into an agreement regarding acquisition of Bribus Holding B.V., a leading Dutch manufacturer of kitchens having an annual turnover of approximately MEUR 65 and around 270 employees.
6/20/20186/20/2018
Cederquist has advised Hemfosa Fastigheter AB in connection with a directed share issue to a number of Swedish and international institutional investors.
6/19/20186/19/2018
Cederquist has advised Addnode Group AB (publ) in connection with a directed share issue to a number of Swedish and international institutional investors.
6/15/20186/15/2018
Cederquist has represented the lending banks in connection with the completion by Patricia Industries, a part of Investor AB (publ), of its acquisition of Piab Group from from EQT for SEK 6.95 bn.
6/11/20186/11/2018
Cederquist has represented Mars, Incorporated, in its acquisition of the AniCura group from Nordic Capital Fund VIII and other sellers.
4/23/20184/23/2018
Cederquist has represented the financing bank in connection with the establishment by Nordika Fastigheter and Partners Group of a joint venture which has acquired a portfolio of real estate properties in Sweden and Finland, with an aggregate value of SEK 1,250,000,000.
4/18/20184/18/2018
Cederquist represented the financing bank in connection with the acquisition, through a newly established joint venture between Starwood Capital Group and Oscar Properties Holding AB (publ), of Primus 1 at Lilla Essingen in Stockholm with a total of 42,000 light BTA from Vasakronan, the purchase price amounting to SEK 920 millions.
4/17/20184/17/2018
Cederquist represented the lenders in connection with Karo Pharma’s acquisition of a product portfolio with an aggregate value of MEUR 260 from the Danish pharmaceutical company LEO Pharma A/S.
4/17/20184/17/2018
Cederquist represented the lender in connection with D. Carnegie´s acquisition of 27 properties located in the Stockholm region, from Akelius, amounting to SEK 2,47 billion.
4/11/20184/11/2018
Cederquist is legal advisor to the US biopharmaceutical company Alexion Pharmaceuticals, Inc. (Alexion) in connection with Alexion’s public cash offer for the shares in Wilson Therapeutics AB that are listed on Nasdaq Stockholm.
3/27/20183/27/2018
Cederquist represents NDX Intressenter AB, a bidding vehicle jointly established by Nordic Capital Fund VIII and Sampo plc, in connection with its public cash offer for Nordax Group AB (publ.).
